Exploring α-Syn's Functions Through Ablation Models: Physiological and Pathological Implications
- PMID: 40389720
- PMCID: PMC12089638
- DOI: 10.1007/s10571-025-01560-2
Exploring α-Syn's Functions Through Ablation Models: Physiological and Pathological Implications
Abstract
A significant advancement in neurodegenerative research was the discovery that α-synuclein (α-Syn/SNCA) plays a part in the pathophysiology of Parkinson's disease (PD). Decades later, the protein's significant impacts on various brain disorders are still being extensively explored. In disease conditions, α-Syn misfolds and forms abnormal aggregates that accumulate in neurons, thus triggering various organellar dysfunctions and ultimately neurodegeneration. These misfolded forms are highly heterogeneous and vary significantly among different synucleinopathies, such as PD, Multiple System Atrophy, or Dementia with Lewy bodies. Though initially believed to be exclusively localized in the brain, numerous pieces of evidence suggest that α-Syn functions transcend the central nervous system, with roles in peripheral functions, such as modulation of immune responses, hematopoiesis, and gastrointestinal regulation. Here, we aim to provide a detailed compilation of cellular functions and pathological phenotypes that are altered upon attenuation of α-Syn function in vitro and in vivo and explore the effects of SNCA gene silencing in healthy and disease states using cellular and animal models.
Keywords: SNCA; α-Syn; Ablation models; Parkinson's disease; Synuclein.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical Approval: Not applicable. Consent to Participate: Not applicable. Consent to Publish: Not applicable.
Figures




Similar articles
-
Loss of functional alpha-synuclein: a toxic event in Parkinson's disease?J Parkinsons Dis. 2012;2(4):249-67. doi: 10.3233/JPD-012138. J Parkinsons Dis. 2012. PMID: 23938255 Free PMC article. Review.
-
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.J Neurochem. 2016 May;137(3):331-59. doi: 10.1111/jnc.13570. Epub 2016 Mar 23. J Neurochem. 2016. PMID: 26852372 Free PMC article. Review.
-
Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson's disease and parkinsonism-dementia of Guam.Cell Death Dis. 2024 Dec 18;15(12):914. doi: 10.1038/s41419-024-07258-5. Cell Death Dis. 2024. PMID: 39695091 Free PMC article.
-
ɑ-Synuclein strains and the variable pathologies of synucleinopathies.J Neurochem. 2016 Oct;139 Suppl 1:256-274. doi: 10.1111/jnc.13595. Epub 2016 Mar 30. J Neurochem. 2016. PMID: 26924014 Review.
-
An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.Mol Neurobiol. 2022 Jan;59(1):620-642. doi: 10.1007/s12035-021-02596-3. Epub 2021 Nov 8. Mol Neurobiol. 2022. PMID: 34750787 Review.
References
-
- Abeliovich A, Schmitz Y, Fariñas I, Choi-Lundberg DL, Ho WH, Castillo PE, Shinsky N, Manuel J, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H (2000) Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25(1):239–252. 10.1016/S0896-6273(00)80886-7 - PubMed
-
- Alam P, Bousset L, Melki R, Otzen DE (2019) α-Synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities. J Neurochem 150(5):522–534. 10.1111/jnc.14808 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous